Zalevsky Jonathan — SEC insider filings
SEC reporting owner CIK 1789857. 41 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2020-08-19 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 37 legs across 34 filings — 449,004 shares, $4,646,291 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 31,111 shares @ $18.30 ($569,331) in NEKTAR THERAPEUTICS, filed 2021-05-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 41 | — | 37 legs · 449,004 sh · $4,646,291 | 19 |
Insider filings — Zalevsky Jonathan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 192 @ $35.85 | EDGAR |
| 2026-08-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 186 @ $71.98 | EDGAR |
| 2026-07-24 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 5,681 @ $70 | EDGAR |
| 2026-06-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 5,538 @ $60.71 | EDGAR |
| 2026-05-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 199 @ $65.51 | EDGAR |
| 2026-02-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 180 @ $73 | EDGAR |
| 2026-01-22 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 3,867 @ $35.67 | EDGAR |
| 2025-12-23 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 2,666 @ $0 · Sale (S): 1,157 @ $54.28 · Grant/award (A): 4,766 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 793 @ $32.43 · Sale (S): 432 @ $33.60 · Sale (S): 189 @ $34.41 · Sale (S): 307 @ $35.69 | EDGAR |
| 2025-09-04 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 485 @ $30.10 | EDGAR |
| 2025-08-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 725 @ $26.59 · Grant/award (A): 16,666 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 10,712 @ $0.67 | EDGAR |
| 2025-02-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 10,300 @ $1.01 | EDGAR |
| 2024-12-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 51,115 @ $0.94 | EDGAR |
| 2024-12-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 135,000 @ $0 · Grant/award (A): 270,000 (derivative) @ $0 · Grant/award (A): 375,000 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 7,785 @ $1.01 | EDGAR |
| 2024-08-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 6,866 @ $1.28 | EDGAR |
| 2024-05-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 7,355 @ $1.75 | EDGAR |
| 2024-02-22 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 9,014 @ $0.68 | EDGAR |
| 2023-12-15 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2023-11-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 9,646 @ $0.49 | EDGAR |
| 2023-08-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 9,703 @ $0.78 | EDGAR |
| 2023-05-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 9,791 @ $0.72 | EDGAR |
| 2023-02-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 10,484 @ $3 | EDGAR |
| 2022-11-18 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 13,460 @ $3.57 | EDGAR |
| 2022-08-19 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 73,716 @ $4.65 | EDGAR |
| 2022-08-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 135,000 @ $0 · Sale (S): 10,560 @ $4.76 · Grant/award (A): 270,000 (derivative) @ $0 | EDGAR |
| 2022-05-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 23,950 @ $0 · Sale (S): 21,673 @ $3.95 | EDGAR |
| 2022-02-18 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 10,912 @ $10.95 | EDGAR |
| 2021-12-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 52,950 @ $0 · Grant/award (A): 94,000 (derivative) @ $0 | EDGAR |
| 2021-11-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 40,150 @ $0 · Sale (S): 20,869 @ $13.16 | EDGAR |
| 2021-10-14 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 71,550 (derivative) @ $0 | EDGAR |
| 2021-08-18 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 7,662 @ $13.83 | EDGAR |
| 2021-05-19 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 31,111 @ $18.30 | EDGAR |
| 2021-02-18 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 24,141 @ $22.37 | EDGAR |
| 2020-12-22 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 71,500 (derivative) @ $0 | EDGAR |
| 2020-11-25 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 16,380 @ $16.40 | EDGAR |
| 2020-11-18 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 29,618 @ $16.93 | EDGAR |
| 2020-08-19 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 26,200 @ $19.67 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1789857 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs